Agilon Health (AGL) Gains from Sales and Divestitures (2022)

Agilon Health (AGL) posted Gains from Sales and Divestitures of $404000.0 for Q4 2022.

Agilon Health (AGL) Gains from Sales and Divestitures (2022) Analysis & Trends

Agilon Health (AGL) has reported Gains from Sales and Divestitures for 1 consecutive years, with $404000.0 the latest figure, recorded in Q4 2022.

  • Gains from Sales and Divestitures for Q4 2022 came in at $404000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $404000.0 (changed N/A YoY), and the FY2022 annual result was $404000.0, changed N/A from the prior year.
  • Gains from Sales and Divestitures was $404000.0 for Q4 2022 at Agilon Health.
  • Over five years, Gains from Sales and Divestitures peaked at $404000.0 in Q4 2022 and troughed at $404000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 Agilon Health 1.86 Bn 1.63 Bn 1.05 Bn

Historic Data

Download Data
DateValue
Dec 31, 2022 404,000.00
Dec 31, 2022 404,000.00